Evidence map›Paper›PMID 35083664›Full record

ArticleJournal of molecular neuroscience : MN2022

GNG12 Targeted by miR-876-5p Contributes to Glioma Progression Through the Activation of the PI3K/AKT Signaling Pathway.

Ling Li, Qiuying Zhang, Leyong Yuan, Yanlong Yang, Xiaobo Wang, Fangfang Liu, Yang Liu, Mingshui Xie

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ling LiDepartment of Clinical Laboratory, Suizhou Hospital, Hubei University of Medicine, Suizhou, 441300, Hubei, China.
Qiuying ZhangDepartment of Clinical Laboratory, Suizhou Hospital, Hubei University of Medicine, Suizhou, 441300, Hubei, China.
Leyong YuanSchool of Basic Medical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Yanlong YangDepartment of Clinical Laboratory, Suizhou Hospital, Hubei University of Medicine, Suizhou, 441300, Hubei, China.
Xiaobo WangMedical Transformation Center, Suizhou Hospital, Hubei University of Medicine, Suizhou, 441300, Hubei, China.
Fangfang LiuDepartment of Clinical Laboratory, Suizhou Hospital, Hubei University of Medicine, Suizhou, 441300, Hubei, China.
Yang LiuDepartment of Clinical Laboratory, Suizhou Hospital, Hubei University of Medicine, Suizhou, 441300, Hubei, China.
Mingshui XieDepartment of Clinical Laboratory, Suizhou Hospital, Hubei University of Medicine, Suizhou, 441300, Hubei, China. mingshuixie5@163.com.ORCID http://orcid.org/0000-0001-9508-5585
Hubei University of Medicine · CN

Funding

2019-2020 General Project of Health Commission of Hubei Province: Study on the Blocking Effect and Mechanism of Interleukin-33 on Tumor Immune Escape WJ2019M099
6 · The paper itself

Abstract

Glioma is one of the most aggressive malignancies and has a poor survival rate. G protein subunit gamma 12 (GNG12), a member of G protein family, has been reported to participate in cancer disorders. However, the role and functional mechanism of GNG12 in glioma are not fully understood. The expression of GNG12 mRNA and miR-876-5p was measured by qRT-PCR. The level of GNG12 protein was measured by western blot. Cell proliferation and cell migration were monitored by CCK-8 assay and wound healing assay. The role of GNG12 on tumorigenicity in vivo was determined by animal models. The interaction between GNG12 and miR-876-5p was validated by dual-luciferase reporter experiment. The phosphorylation levels of PI3K and AKT were monitored by western blot. The upregulated expression of GNG12 was identified in tumor tissues and cells of glioma. GNG12 knockdown inhibited glioma cell growth and migration, and slowed tumor development in vivo. Besides, GNG12 knockdown weakened the phosphorylation levels of PI3K and AKT. GNG12 was verified to be a target of miR-876-5p whose enrichment suppressed the expression and function of GNG12. MiR-876-5p repressed glioma cell proliferation, migration, and the activity of PI3K/AKT signaling by targeting GNG12. MiR-876-5p-targeted GNG12 contributes to the malignant development of glioma by increasing the PI3K/AKT signaling activity.

Indexed as

GliomaGTP-Binding Protein gamma SubunitsMicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktAnimalsCell Line, TumorCell MovementCell ProliferationSignal TransductionGTP-Binding Protein gamma SubunitsMicroRNAsPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktGliomaGNG12miR-876-5pPI3K/AKT

Identifiers

PMID35083664
OpenAlexW4210789881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.